Ditekiren

This classification denotes an antihypertensive agent with the molecular formula C50H75N9O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5355S3W1IS, chemically known as tert-butyl (2s)-2-(((alphas)-alpha-(((1s)-1-(((1s,2s,4s)-2-hydroxy-1-isobutyl-5-methyl-4-(((1s,2s)-2-methyl-1-((2-pyridylmethyl)carbamoyl)butyl)carbamoyl)hexyl)carbamoyl)-2-imidazol-4-ylethyl)methylcarbamoyl)phenethyl)carbamoyl)-1-pyrrolidinecarboxylate but generally known as ditekiren, which bears US NIH Compound Identifier 5464201. European Medicines Agency schedules Ditekiren in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06329MIG. The term DITEKIREN is an International Non-Proprietary Name. DITEKIREN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ditekiren under HS 29333999 and SITC 51574. As of Q4 2014, DITEKIREN remains the US FDA Preferred Term for this commodity. Ditekiren bears US NLM identifiers UMLS ID C0077636 and NCI Concept Code C95291. SMILES: OC(C(NC(=O)C(N(C(=O)C(NC(=O)C1N(CCC1)C(=O)OC(C)(C)C)Cc1ccccc1)C)Cc1[nH]cnc1)CC(C)C)CC(C(C)C)C(=O)NC(C(CC)C)C(=O)NCc1ncccc1.